Iradimed (NASDAQ:IRMD) Rating Lowered to “Buy” at StockNews.com
StockNews.com cut shares of Iradimed (NASDAQ:IRMD – Free Report) from a strong-buy rating to a buy rating in a research report report published on Tuesday. Separately, Roth Mkm reaffirmed a “buy” rating and issued a $72.00 target price (up from $60.00) on shares of Iradimed in a research note on Friday, February 14th. Read Our […]
StockNews.com cut shares of Iradimed (NASDAQ:IRMD – Free Report) from a strong-buy rating to a buy rating in a research report report published on Tuesday. Separately, Roth Mkm reaffirmed a “buy” rating and issued a $72.00 target price (up from $60.00) on shares of Iradimed in a research note on Friday, February 14th. Read Our […]
